Abstract
Background: Leukemias are the primary cause of cancer-related mortality, AML has the lowest survival rate being one of the more
prevalent leukemias in adults worldwide as well as in Iraq.
Materials and methods: The descriptive, epidemiological study was conducted on 412 newly diagnosed AML patients as a sample
of the Iraqi population enrolled in the Oncology Center in the Medical City of Baghdad province and the Basrah Oncology Center
in Basrah province during 2022. Their mean age was 42.09 ± 22.32 years.
Results: Among 412 patients, a median age of 40.05 was the predominant Iraqi AML which was lower than that of other developed
countries. The disease was more predominant in age categories (≥70) years and (60-69) years with 18.52 % and 16.26% respectively.
The majority of the patients were suffering from pallor (65.29%), fever (49.76%), leukocytosis (43.20%) or cytopenia (27.18%) at
the time of presentation.
Conclusion: The study indicates that the disease is highly prevalent, with a younger median age than in other nations, and the most
prevalent subtype of AML was APL. The clinical and epidemiological features have effects on comprehending incidence and
disease development.
Main Subjects
)
